Accro Bioscience Advances Rare Disease Drug Development
Shanghai, China, September 11, 2026 Accro Bioscience has announced that its investigational AC-101 tablets have been included in the...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Shanghai, China, September 11, 2026 Accro Bioscience has announced that its investigational AC-101 tablets have been included in the...
Berlin, Germany and New York, NY, September 12, 2026 Aignostics has launched PathoSearch, a new AI-powered visual search engine...
Irving, Texas, U.S, September 8, 2026 Caris Life Sciences, an artificial intelligence and precision medicine company, has launched a...
Chicago, Ill. – August 28, 2026 GE HealthCare announced three additions to its Vivid™ cardiovascular ultrasound portfolio — Vivid...
Irving, Texas, United States, Aug 27, 2026 Caris Life Sciences has announced the publication of a study in npj...
Cambridge, Massachusetts, United States & Amsterdam, Netherlands, Aug 26, 2026 Royal Philips has received an award of up to...
Columbus, Ohio, August 18, 2026 Andelyn Biosciences, Inc., a patient-focused cell and gene therapy contract development and manufacturing organization...
New Brunswick, New Jersey, August 18, 2026 Johnson & Johnson has published a new Future of Digital Surgery report...
SHANGHAI and HONG KONG, August 18, 2026 Antengene Corporation Limited, a commercial-stage global biotechnology company focused on innovative therapies...
CAMPBELL, Calif., August 18, 2026 Enlil, Inc. has introduced a four-layer governed AI architecture designed to help medical device...
